C. Chung

Clinical Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Lung Cancer: Experience of Linko Chang-Gung Memorial Hospital

T. Yen, Y. Tsai, Sheng-Chieh Chan, 2005 .

A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer.

H. Groen, J. Milanowski, T. Ciuleanu, 2013, Lung cancer.